Fanélie Jouenne - Concepedia

Author

Fanélie Jouenne

Assistance Publique – Hôpitaux de Paris ORCID

Also Known As

F Jouenne, F. Jouenne, Fanelie Jouenne, Fanélie Jouenne, Jouenne, Fanélie, Yasser Riazalhosseini

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Assistance Publique – Hôpitaux de Paris Université Paris Cité Inserm Hôpital Saint-Louis Centre National de la Recherche Scientifique

About

Fanélie Jouenne is an author at Assistance Publique – Hôpitaux de Paris.

Fanélie Jouenne

Publications

348

Citations

H-Index

Page 1

	Year	Citations
Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients Adèle de Masson, Delphine Darbord, Gábor Dobos, Blood	2021	71
Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Fanélie Jouenne, Sylvie Chevret, Emmanuelle Bugnet, European Respiratory Journal	2019	62
Discoidin domain receptors: A promising target in melanoma Coralie Reger de Moura, Maxime Battistella, Anjum Sohail, Pigment Cell & Melanoma Research	2019	33
Porocarcinomas with <i>PAK1/2/3</i> fusions: a series of 12 cases Thibault Kervarrec, Danna Westphal, Daniel Pissaloux, Histopathology	2024	21
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcoma Fanélie Jouenne, Isaure Chauvot de Beauchêne, Emeline Bollaert, Journal of Medical Genetics	2017	20
Recurrent <i>PAK2</i> rearrangements in poroma with folliculo‐sebaceous differentiation Thibault Kervarrec, Daniel Pissaloux, Sandrine Paindavoine, Histopathology	2023	20
Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in <i>BRAF</i> V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism Baptiste Louveau, Matthieu Resche‐Rigon, Thierry Lesimple, Clinical Cancer Research	2021	18
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors Baptiste Louveau, Julie Delyon, Coralie Reger de Moura, Oncotarget	2019	17
Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease Yannick Dieudonné, Marc‐Antoine Silvestrini, Antoine Dossier, British Journal of Haematology	2023	17
Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma Coralie Reger de Moura, Laëtitia Vercellino, Fanélie Jouenne, Translational Oncology	2019	15

Page 1